Evotec SE (EVO) Gross Profit (QoQ) (2009 - 2025)
Evotec SE (EVO) Gross Profit (QoQ) (2009 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn |
| 3 | Zoetis | 32.67 Bn | 30.73 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.69 Bn | 23.63 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.12 Bn | 20.97 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.24 Bn | 18.44 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Evotec SE | 344.50 Mn | 343.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 100.13% |
| Dec 31, 2024 | 145.35% |
| Dec 31, 2023 | 259.01% |
| Sep 30, 2023 | -28.97% |
| Dec 31, 2022 | 226.17% |
| Sep 30, 2022 | -13.08% |
| Jun 30, 2022 | -9.04% |
| Mar 31, 2022 | -68.15% |
| Dec 31, 2021 | 123.53% |
| Sep 30, 2021 | 64.97% |
| Jun 30, 2021 | -16.62% |
| Mar 31, 2021 | -65.20% |
| Dec 31, 2020 | 152.01% |
| Sep 30, 2010 | -21.57% |
| Jun 30, 2010 | -99.81% |
| Mar 31, 2010 | 31,511.74% |
| Jun 30, 2009 | -99.86% |